IL6 and amyotrophic lateral sclerosis: Inflammatory markers, interleukin-1β (IL-1β), IL-6, IL-8, tumor necrosis factor-α (TNF-α), and TNF receptor-1, are significantly increased in ALS patients (Hu et al., 2017).